How small peptides block and reverse serpin polymerisation.
暂无分享,去创建一个
D. Lomas | P. Stein | Aiwu Zhou | R. Carrell | J. Huntington | P. Sivasothy
[1] P. Stein,et al. Serpin Polymerization Is Prevented by a Hydrogen Bond Network That Is Centered on His-334 and Stabilized by Glycerol* , 2003, The Journal of Biological Chemistry.
[2] David A. Lomas,et al. Human genetics and disease: Serpinopathies and the conformational dementias , 2002, Nature Reviews Genetics.
[3] D. Lomas,et al. 6-mer Peptide Selectively Anneals to a Pathogenic Serpin Conformation and Blocks Polymerization , 2002, The Journal of Biological Chemistry.
[4] D. Lomas,et al. Alpha1-antitrypsin deficiency--a model for conformational diseases. , 2002, The New England journal of medicine.
[5] D. Selkoe. Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.
[6] J. Whisstock,et al. Cleaved antitrypsin polymers at atomic resolution , 2008, Protein science : a publication of the Protein Society.
[7] R. Read,et al. Structure of a serpin–protease complex shows inhibition by deformation , 2000, Nature.
[8] P. Lansbury,et al. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[9] R. Read,et al. Inactive conformation of the serpin alpha(1)-antichymotrypsin indicates two-stage insertion of the reactive loop: implications for inhibitory function and conformational disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[10] R. Read,et al. A 2.6 A structure of a serpin polymer and implications for conformational disease. , 1999, Journal of molecular biology.
[11] D. Lomas,et al. Familial dementia caused by polymerization of mutant neuroserpin , 1999, Nature.
[12] R M Esnouf,et al. Further additions to MolScript version 1.4, including reading and contouring of electron-density maps. , 1999, Acta crystallographica. Section D, Biological crystallography.
[13] D E McRee,et al. XtalView/Xfit--A versatile program for manipulating atomic coordinates and electron density. , 1999, Journal of structural biology.
[14] R. Carrell,et al. Conformational changes and disease--serpins, prions and Alzheimer's. , 1998, Current opinion in structural biology.
[15] J. Abrahams,et al. Implications for function and therapy of a 2.9 A structure of binary-complexed antithrombin. , 1998, Journal of molecular biology.
[16] Aiwu Zhou,et al. Antithrombins Wibble and Wobble (T85M/K): archetypal conformational diseases with in vivo latent-transition, thrombosis, and heparin activation. , 1998, Blood.
[17] R J Read,et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.
[18] D. Musil,et al. Interfering with the inhibitory mechanism of serpins: crystal structure of a complex formed between cleaved plasminogen activator inhibitor type 1 and a reactive-centre loop peptide. , 1998, Structure.
[19] F. Cohen,et al. Prion Protein Biology , 1998, Cell.
[20] J. Abrahams,et al. The anticoagulant activation of antithrombin by heparin. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[21] R. Carrell,et al. Mechanisms of antithrombin polymerisation and heparin activation probed by the insertion of synthetic reactive loop peptides. , 1997, Biological chemistry.
[22] P. Andrew Karplus,et al. Improved R-factors for diffraction data analysis in macromolecular crystallography , 1997, Nature Structural Biology.
[23] J. Whisstock,et al. Importance of the release of strand 1C to the polymerization mechanism of inhibitory serpins , 1997, Protein science : a publication of the Protein Society.
[24] E A Merritt,et al. Raster3D: photorealistic molecular graphics. , 1997, Methods in enzymology.
[25] R. Read,et al. Improved Structure Refinement Through Maximum Likelihood , 1996 .
[26] P. Stein,et al. Biological implications of a 3 A structure of dimeric antithrombin. , 1994, Structure.
[27] M. Delarue,et al. Crystal structure of cleaved bovine antithrombin III at 3.2 A resolution. , 1993, Journal of molecular biology.
[28] D. Lomas,et al. Effect of the Z mutation on the physical and inhibitory properties of alpha 1-antitrypsin. , 1993, Biochemistry.
[29] D. Lomas,et al. The mechanism of Z α1-antitrypsin accumulation in the liver , 1993, Nature.
[30] J. Enghild,et al. Conformation of the reactive site loop of alpha 1-proteinase inhibitor probed by limited proteolysis. , 1992, Biochemistry.
[31] S. Olson,et al. Conversion of antithrombin from an inhibitor of thrombin to a substrate with reduced heparin affinity and enhanced conformational stability by binding of a tetradecapeptide corresponding to the P1 to P14 region of the putative reactive bond loop of the inhibitor. , 1992, The Journal of biological chemistry.
[32] P. Kraulis. A program to produce both detailed and schematic plots of protein structures , 1991 .
[33] J. Zou,et al. Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.
[34] R. Huber,et al. Structural transition of α1‐antitrypsin by a peptide sequentially similar to β‐strand s4A , 1990 .
[35] R. Huber,et al. Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. , 1984, Journal of molecular biology.
[36] W. Krivit,et al. Cirrhosis associated with alpha-1-antitrypsin deficiency: a previously unrecognized inherited disorder. , 1969, The Journal of laboratory and clinical medicine.
[37] C. Laurell,et al. The Electrophoretic α;1-Globulin Pattern of Serum in α;1-Antitrypsin Deficiency , 1963 .